21st International Conference on Progress in Vaccination Against Cancer (PIVAC-22)
26. September - 28. September
21st International Conference on Progress in Vaccination Against Cancer (PIVAC-22) which will be held 26th–28th September 2022 in Turin, Italy at the Molecular Biotechnology Center.
PIVAC has a long tradition of international conferences, hosted in different European cities annually (except 2020) since the first was held in 2000 in Cambridge. This was prompted by the pioneering vision of a small (at that time) community of researchers exploring cancer vaccination and immunotherapy, at a time when this field was still far from being mainstream. Now that immunotherapy has proven to be a breakthrough in cancer treatment, the objectives of PIVAC conference are to gather, share and exchange experiences and ideas, promote interactions between speakers and participants and encourage stimulating discussions, provide network opportunities and stimulate new collaborations.
The meeting will cover the most recent advances in the field of cancer immunotherapy, with a focus on the tumor microenvironment, addressing how alterations to its molecular and metabolic features and to the microbiota impact the response to immunotherapy.
Call for Abstracts now open! (until 1st June 2022)
The Scientific Committee invites you to participate actively in this congress and make it an extraordinary occasion for the exchange of thoughts and experiences. We look forward to receiving abstracts for consideration and inclusion in the program as poster presentations in dedicated poster sessions or oral presentations in plenary symposia.
Abstracts must be submitted online, from March 15 to June 01, 2022, via the PIVAC-22 Congress website.
Preliminary program available!
More than 20 international invited speakers have already confirmed their participation in PIVAC-22! Our scientific sessions will cover the following topics:
– tumor microenvironment and mechanisms of immune resistance and immune modulation by cancer cells
– influence of metabolism and microbiota on tumor immunology and immunotherapy.
– progress in vaccination against cancer: from the bench to the bedside,
– strategies to identify novel immunotherapeutic targets and to monitor the immune response
– novel immunotherapeutic and combined strategies for cancer treatment